Medical devices, healthcare technology and the business of care
510(k) clearance · K254246

LT Antibacterial Foam with Silver Dressing

Zhejiang Longterm Medical Technology Co., Ltd. · Decision date Sep 10, 2026

MEDTECHLEDGER EXPLANATIONK254246

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 09/10/2026 for K254246, submitted by Zhejiang Longterm Medical Technology Co., Ltd. of Deqing, CN. The device is listed as LT Antibacterial Foam with Silver Dressing, classified under the occlusive wound dressing category (21 CFR 878.4020), product code NAD, with FRO as a subsequent product code. The application was received 12/29/2025 and reviewed by the General & Plastic Surgery panel as a traditional 510(k); the page states it was not reviewed by a third party and was recorded as a combination product.

SESE means the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The public record does not identify the predicate device, the specific silver component or foam construction details, or the basis for the equivalence finding, and no summary statement is included in the supplied data. A predetermined change control plan was not authorized. Whether the silver component raises any separate regulatory consideration is not addressed in the available fields.

Readers should treat this as a dated clearance record only. The page does not provide indications, performance data, or labeling, so no clinical or comparative conclusions can be drawn from it.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 10, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254246
Regulatory pathway
510(k) premarket notification
Product code
NAD
Decision code
SESE
Decision date
Sep 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Dressing, Wound, Occlusive.

Product code
NAD
FDA device class
1

FDA decision timeline

  1. K254246 received

    Application receipt date recorded by FDA.

  2. K254246 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Zhejiang Longterm Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Deqing

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records